Sign In

Liza Squires, M.D.

Chief Medical Officer at Neuren Pharmaceuticals

Dr. Liza Squires is a distinguished medical professional with a proven track record in pediatric therapeutics and drug development.

Currently, Dr. Squires holds the esteemed position of Chief Medical Officer at Neuren Pharmaceuticals, where she spearheads the development of innovative treatments for Central Nervous System disorders affecting children.

Her illustrious career spans over two decades, marked by significant contributions in early and late-stage drug development at reputable pharmaceutical companies like Johnson & Johnson, Shire Pharmaceuticals, Lumos Pharma, and Aevi Genomic Medicine.

Dr. Squires' expertise has been instrumental in the successful global regulatory approvals of renowned medications such as Topamax®, Daytrana®, Vyvanse®, Intuniv®, and Nulibry®.

She is a published author in esteemed peer-reviewed journals, advocating for pediatric therapeutics advancement, and actively engaging with advocacy groups.

Dr. Squires' educational background includes a Doctor of Medicine (M.D.) from Michigan State University and a BS in Zoology / Anthropology from the University of Michigan.

She is board certified in General Pediatrics and Neurology with Special Competence in Child Neurology, having trained at prestigious institutions like Yale University and Massachusetts General Hospital.

Throughout her career, Dr. Squires has held pivotal roles such as Vice President and Therapeutic Area Head Neuroscience at Aevi Genomic Medicine, Chief Medical Officer at Lumos Pharma, and Vice President, Global Clinical Development and Innovation at Shire Pharmaceuticals.

Dr. Liza Squires' extensive experience in pediatric drug development, coupled with her unwavering commitment to advancing healthcare for children, solidifies her as a prominent figure in the medical field.

Liza Squires, M.D.
Add to my network

Location

Greater Philadelphia